Number of pages: 59
Posted: 18 Feb 2022
Dapeng Li,
David Martinez,
Alexandra Schäfer,
Haiyan Chen,
Maggie Barr,
Laura L. Sutherland,
Esther Lee,
Rob Parks,
Dieter Mielke,
Whitney Edwards,
Amanda Newman,
Kevin W. Bock,
Mahnaz Minai,
Bianca M. Nagata,
Matthew Gagne,
Daniel Douek,
C. Todd DeMarco,
Thomas Denny,
Thomas H. Oguin,
Alecia Brown,
Wes Rountree,
Yunfei Wang,
Katayoun Mansouri,
Robert J. Edwards,
Guido Ferrari,
Gregory D. Sempowski,
Amanda Eaton,
Juanjie Tang,
Derek W. Cain,
Sampa Santra,
Norbert Pardi,
Drew Weissman,
Mark Tomai,
Christopher Fox,
Ian N. Moore,
Hanne Andersen, Mark G. Lewis,
Hana Golding,
Robert A. Seder,
Surender Khurana,
Ralph S. Baric,
David C. Montefiori,
Kevin O. Saunders and
Barton F. Haynes
Duke University - Duke Human Vaccine Institute, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Department of Surgery, Duke University - Duke Human Vaccine Institute, Duke University - Department of Surgery, Government of the United States of America - Infectious Disease Pathogenesis Section, Comparative Medicine Branch, Government of the United States of America - Infectious Disease Pathogenesis Section, Comparative Medicine Branch, Government of the United States of America - Infectious Disease Pathogenesis Section, Comparative Medicine Branch, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Department of Surgery, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration - Division of Viral Products, Duke University - Duke Human Vaccine Institute, Beth Israel Deaconess Medical Center, University of Pennsylvania - Department of Microbiology, University of Pennsylvania - Department of Microbiology, Corporate Research Materials Lab, 3M Company, Infectious Disease Research Institute, Government of the United States of America - Infectious Disease Pathogenesis Section, Comparative Medicine Branch, BIOQUAL, BIOQUAL, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration - Division of Viral Products, Government of the United States of America - Vaccine Research Center, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration - Division of Viral Products, University of North Carolina (UNC) at Chapel Hill - Department of Microbiology and Immunology, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute and Duke University - Duke Human Vaccine Institute
